296 related articles for article (PubMed ID: 28189609)
21. Analysis of High-, Intermediate-, and Low-Volume Surgeons When Performing Hysterectomy for Uterovaginal Prolapse.
Morgan DM; Pulliam S; Adam RA; Swenson C; Guire K; Kamdar N; Guaderrama N
Female Pelvic Med Reconstr Surg; 2016; 22(1):43-50. PubMed ID: 26516812
[TBL] [Abstract][Full Text] [Related]
22. Very Low Rates of Ureteral Injury in Laparoscopic Hysterectomy Performed by Fellowship-trained Minimally Invasive Gynecologic Surgeons.
Gupta S; Maghsoudlou P; Ajao M; Einarsson JI; King LP
J Minim Invasive Gynecol; 2022 Sep; 29(9):1099-1103. PubMed ID: 35691546
[TBL] [Abstract][Full Text] [Related]
23. The impact of fellowship surgical training on operative time and patient morbidity during robotics-assisted sacrocolpopexy.
Carter-Brooks CM; Du AL; Bonidie MJ; Shepherd JP
Int Urogynecol J; 2018 Sep; 29(9):1317-1323. PubMed ID: 28889173
[TBL] [Abstract][Full Text] [Related]
24. Apical suspension is underutilized for repair of stage IV pelvic organ prolapse: an analysis of national practice patterns in the United States.
Slopnick EA; Chapman GC; Roberts K; Sheyn DD; El-Nashar S; Mahajan ST
Int Urogynecol J; 2021 Apr; 32(4):791-797. PubMed ID: 32507910
[TBL] [Abstract][Full Text] [Related]
25. Pelvic organ prolapse following hysterectomy on benign indication: a nationwide, nulliparous cohort study.
Husby KR; Gradel KO; Klarskov N
Am J Obstet Gynecol; 2022 Mar; 226(3):386.e1-386.e9. PubMed ID: 34688595
[TBL] [Abstract][Full Text] [Related]
26. Apical Suspension Utilization at the Time of Vaginal Hysterectomy for Pelvic Organ Prolapse Varies With Surgeon Specialty.
Sheyn D; El-Nashar S; Mahajan ST; Mangel JM; Chapman GC; Hijaz AK
Female Pelvic Med Reconstr Surg; 2020 Jun; 26(6):370-375. PubMed ID: 30807336
[TBL] [Abstract][Full Text] [Related]
27. Regional Performance of Apical Support Procedures at Time of Hysterectomy for Benign Indications: What Is the Role of Surgeon Training?
Putman JG; Meister MR; Lenger SM; Lowder JL
Female Pelvic Med Reconstr Surg; 2021 Jul; 27(7):421-426. PubMed ID: 32701766
[TBL] [Abstract][Full Text] [Related]
28. The incidence of transfusion and associated risk factors in pelvic reconstructive surgery.
Pandya LK; Lynch CD; Hundley AF; Nekkanti S; Hudson CO
Am J Obstet Gynecol; 2017 Nov; 217(5):612.e1-612.e8. PubMed ID: 28709582
[TBL] [Abstract][Full Text] [Related]
29. Implementation of a urogynecology-specific enhanced recovery after surgery (ERAS) pathway.
Carter-Brooks CM; Du AL; Ruppert KM; Romanova AL; Zyczynski HM
Am J Obstet Gynecol; 2018 Nov; 219(5):495.e1-495.e10. PubMed ID: 29913175
[TBL] [Abstract][Full Text] [Related]
30. Current Clinical Practice Patterns in Total Vaginal Hysterectomy.
Clarke B; Dieter AA; Chou J; Woodburn K
South Med J; 2023 Oct; 116(10):795-805. PubMed ID: 37788813
[TBL] [Abstract][Full Text] [Related]
31. Physician and Hospital-level Variation in Hemostatic Agent Use in Benign Gynecologic Procedures.
Stachowicz AM; Lambert JW; Hohmann SF; Whiteside JL
J Minim Invasive Gynecol; 2022 Oct; 29(10):1149-1156. PubMed ID: 35781055
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for pelvic organ prolapse recurrence after sacrospinous hysteropexy or vaginal hysterectomy with uterosacral ligament suspension.
Schulten SF; Detollenaere RJ; IntHout J; Kluivers KB; Van Eijndhoven HW
Am J Obstet Gynecol; 2022 Aug; 227(2):252.e1-252.e9. PubMed ID: 35439530
[TBL] [Abstract][Full Text] [Related]
33. Laparoscopic Uterosacral Ligament Hysteropexy vs Total Vaginal Hysterectomy with Uterosacral Ligament Suspension for Anterior and Apical Prolapse: Surgical Outcome and Patient Satisfaction.
Haj-Yahya R; Chill HH; Levin G; Reuveni-Salzman A; Shveiky D
J Minim Invasive Gynecol; 2020 Jan; 27(1):88-93. PubMed ID: 30802607
[TBL] [Abstract][Full Text] [Related]
34. IUGA guidelines for training in female pelvic medicine and reconstructive pelvic surgery (FPM-RPS). Updated guidelines 2010.
Drutz HP;
Int Urogynecol J; 2010 Dec; 21(12):1445-53. PubMed ID: 21063823
[No Abstract] [Full Text] [Related]
35. Pelvic Organ Prolapse Surgery in Academic Female Pelvic Medicine and Reconstructive Surgery Urology Practice in the Setting of the Food and Drug Administration Public Health Notifications.
Younger A; Rac G; Clemens JQ; Kobashi K; Khan A; Nitti V; Jacobs I; Lemack GE; Brown ET; Dmochowski R; Maclachlan L; Mourtzinos A; Ginsberg D; Koski M; Rames R; Rovner E
Urology; 2016 May; 91():46-51. PubMed ID: 26845051
[TBL] [Abstract][Full Text] [Related]
36. Surgical treatment of pelvic organ prolapse in women aged ≥75 years in Hong Kong: a multicentre retrospective study.
Wong D; Lee YT; Tang GPY; Chan SSC
Hong Kong Med J; 2022 Apr; 28(2):107-115. PubMed ID: 35354666
[TBL] [Abstract][Full Text] [Related]
37. Robotic-assisted laparoscopic surgery for hysterectomy and pelvic organ prolapse repair.
Paraiso MF
Fertil Steril; 2014 Oct; 102(4):933-8. PubMed ID: 25274486
[TBL] [Abstract][Full Text] [Related]
38. Current trends and future perspectives in pelvic reconstructive surgery.
Aubé M; Tu LM
Womens Health (Lond); 2018; 14():1745506518776498. PubMed ID: 29772955
[TBL] [Abstract][Full Text] [Related]
39. Comparison of 30-Day Readmission After Same-Day Compared With Next-Day Discharge in Minimally Invasive Pelvic Organ Prolapse Surgery.
Berger AA; Tan-Kim J; Menefee SA
Obstet Gynecol; 2020 Jun; 135(6):1327-1337. PubMed ID: 32459424
[TBL] [Abstract][Full Text] [Related]
40. Factors affecting women's decision between uterine-preserving versus hysterectomy-based surgery for pelvic organ prolapse.
Ramage K; Ducey A; Scime NV; Knox E; Brennand EA
Womens Health (Lond); 2023; 19():17455057231181015. PubMed ID: 37387264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
